Co-emergence of linezolid-resistant Staphylococcus aureus and Enterococcus faecium in a patient with methicillin-resistant S. aureus pneumonic sepsis.
Dongheui
D
An
Mi Young
MY
Lee
Tae Dong
TD
Jeong
Heungsup
H
Sung
Mi-Na
MN
Kim
Sang-Bum
SB
Hong
D000081:Acetamides / Q000008:administration & dosage* / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D016984:Enterococcus faecium / Q000187:drug effects / Q000235:genetics; D017809:Fatal Outcome; D016908:Gram-Positive Bacterial Infections / Q000150:complications*; D006801:Humans; D000069349:Linezolid; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus / Q000235:genetics / Q000502:physiology*; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D023303:Oxazolidinones / Q000008:administration & dosage* / Q000627:therapeutic use*; D011023:Pneumonia, Staphylococcal / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D012338:RNA, Ribosomal, 23S / Q000235:genetics; D012772:Shock, Septic / Q000150:complications*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000235:genetics; D013997:Time Factors
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D012338:RNA, Ribosomal, 23S; D000069349:Linezolid